Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer
Mayu O. Frank, Julia Kaufman, Suyan Tian et al. · 2010
Read Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer by Mayu O. Frank, Julia Kaufman, Suyan Tian et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012367.txt.
Description
Mayu Frank, Julia Kaufman, Suyan Tian and colleagues ran an early prostate cancer vaccine trial reported in PLOS ONE in 2010. Their idea came from patients whose immune systems attacked their own tumors after nerve damage, showing that the body can mount strong anti-tumor defense. The team asked whether a vaccine could safely spark that kind of natural immunity on purpose.
The trial tested whether the vaccine was safe and whether patients' immune systems responded. The approach uses the patient's own tumor signals rather than a single lab-made target. Early trials like this one cannot prove a cure, but they show whether the concept deserves larger tests. For prostate cancer, which often grows slowly, immune treatments remain an active hope.
Catalog record
| CREATOR | Mayu O. Frank, Julia Kaufman, Suyan Tian et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012367